The Medicare Oncology Care Model payment demonstration should evolve to focus more directly on lowering prescription drug costs and improving quality of care by aligning pricing and prescribing with value, the Community Oncology Alliance says in a recent proposal to the US Health and Human Services Physician-Focused Payment Model Technical Advisory Committee.
The OCM launched 1 July 2016 as a five-year modified bundling experiment involving Medicare beneficiaries undergoing chemotherapy for all cancers.
